Phase 2 Hepato Cellular Carcinoma Clinical Trials
8 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–8 of 8 trials
Recruiting
Phase 2
SHIELD: Sorafenib Hand-foot Syndrome Inhibition With Pre-Emptive Local Delivery of Topical Indomethacin
Hepato Cellular Carcinoma (HCC)Hand Foot Skin Syndrome
National Taiwan University Hospital39 enrolled1 locationNCT07560566
Recruiting
Phase 2
A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma
Hepato Cellular Carcinoma (HCC)
Fudan University350 enrolled1 locationNCT07328009
Recruiting
Phase 2
Becotatug Vedotin (MRG003) in Previously Treated Advanced Hepatocellular Carcinoma
Hepato Cellular Carcinoma (HCC)
Fudan University40 enrolled1 locationNCT07536789
Recruiting
Phase 2
IIT2025-03-YANG-LIFT-HCC
Hepato Cellular Carcinoma
Ju Dong Yang41 enrolled1 locationNCT07489976
Recruiting
Phase 2Phase 3
Transarterial Chemoembolization (TACE) Plus ABCB1 Inhibition Versus TACE Alone in Patients With Hepatocellular Carcinoma
Hepato Cellular Carcinoma (HCC)
University Hospital, Basel, Switzerland152 enrolled3 locationsNCT07302919
Recruiting
Phase 2
Fecal Microbiota Transplantation to RESCUE Patients With Unresectable Hcc Progressors to First Line Therapy With AtezolizUmaB and Bevacizumab
Hepato Cellular Carcinoma (HCC)
IRCCS Azienda Ospedaliero-Universitaria di Bologna15 enrolled1 locationNCT07276100
Recruiting
Phase 2
HAIC Combined with Donafenib and Sintilimab As Perioperative Treatment for Resectable Hepatocellular Carcinoma Patients At High Risk of Recurrence
Hepato Cellular Carcinoma (HCC)
Fudan University165 enrolled3 locationsNCT06812039
Recruiting
Phase 2
PD-L1 Antibody + Bevacizumab With Hepatic Arterial Infusion Chemotherapy for Advanced HCC
Hepato Cellular Carcinoma (HCC)
West China Hospital36 enrolled1 locationNCT06742424